Open Orphan gets £4.3 million challenge study contract win with global vaccine company
LONDON: Open Orphan plc (ORPH), announced a new £4.3 million contract to conduct a human viral challenge study utilising one of its 8 traditional challenge study models for another of the global top 10 vaccine companies. This trial will be…